Research Article
Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes
Table 4
Sensitivity analysis of odds ratio of hypoglycaemia and lipid profiles for cardiovascular disease after exclusion of 408 patients who used lipid lowering drugs.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Model one: not adjusted for other variables. Model two: adjusted for age, sex, BMI, systolic blood pressure and log-transformed urinary albumin to creatinine ratio, and drug use (statins, other lipid lowering drugs, renin-angiotensin system inhibitors, oral antidiabetes drugs [OADs] only, glucagon-like peptide-1 based treatment, basal insulin based treatment, and premixed insulin based treatment). Model three: further adjusted for LDL-C, HDL-C, and triglyceride. Model four: not adjusted for other variables. Model five: adjusted for age, sex, BMI, systolic blood pressure, LDL-C, HDL-C, triglyceride and log-transformed urinary albumin to creatinine ratio, and drug use (statins, other lipid lowering drugs, renin-angiotensin system inhibitors, oral antidiabetes drugs [OADs] only, glucagon-like peptide-1 based treatment, basal insulin based treatment, and premixed insulin based treatment). Model six: adjusted for the variables listed in model five and hypoglycaemia. |